OMRF brain tumor drug receives rare disease designations from the FDA September 2, 2020 The drug treats fast-growing, deadly brain cancers with no effective treatment.
Play It Again, Bob How one OMRF scientist’s refusal to give up on a failed stroke drug has yielded new hope for treating brain cancer and hearing loss